Analytics
- Ref-No.Technology
- 01-00976NMR glass capillary sealing device
- 03-00359mRNA interactome capture
- 03-00459Autofocus-control of a microscope including an electrically tunable lens
- 03-00462SPACE-Seq: Localizing Spatial Gene Expression on Single-Cell Level
- 06-00053Cost-efficient Disposable Filtration Microtiter Plates for High Throughput Applications
- 14-00022Man6P-specific single chain antibody fragment for detection of mucolipidosis and optimization of enzyme production for ERT
- 14-00073Improved endotoxin test for the quality control of biologics, overcoming low endotoxin recovery (LER) / low lipopolysaccharide recovery (LLR) phenomenon
- 15-00385LNCRNAS GADLOR 1 + 2 FOR DIAGNOSIS AND TREATMENT OF CARDIAC HYPERTROPHY
- 15-00604Novel Diagnostic Marker For Early Detection Of Bladder Cancer
- 22-00022Gene List Significance Index
- 32-00030Method and arrangement for identification and correction of optical aberrations
- 32-00071A sensitive assay for measuring extracellular NAD+ in blood and other human body fluids
- 44-00001Technology enabling a comprehensive analysis of blood flow in vessels
Animal Models
- Ref-No.Technology
- 002249B10.129S2(B6)-Igh-6tm1Cgn/J
- 002250B10.129P2(B6)-Il10tm1Cgn/J
- 002251B6.129P2-Il10tm1Cgn/J
- 002253B6.129P2-Il4tm1Cgn/J
- 002288B6.129S2-Igh-6tm1Cgn/J
- 002397129-Cd5tm1Cgn/J
- 002399129-Igh-5tm1Cgn/J
- 002400C57BL/6-Igk-Ctm1Cgn/J
- 002401B6.129S2-Igll1tm1Cgn/J
- 002405B6.129P2-Ncam1tm1Cgn/J
- 002438B6.129P2-Igh-Jtm1Cgn/J
- 002479STOCK Il2rgtm1Cgn/J
- 002527STOCK Tg(Mx1-cre)1Cgn/J
- 002538C.129P2(B6)-Igh-5tm1Cgn/J
- 002858STOCK Tg(balancer1)2Cgn/J
- 002859STOCK Tg(balancer2)3Cgn/J
- 002965C57BL/6-Itgb7tm1Cgn/J
- 003465BALB/c-Tg(CMV-cre)1Cgn/J
- 003556B6.Cg-Tg(Mx1-cre)1Cgn/J
- 003968C3Bir.129P2(B6)-Il10tm1Cgn/J
- 004126C.129P2-Cd19tm1(cre)Cgn/J
- 004192STOCK Mttptm2Sgy Ldlrtm1Her Apobtm2Sgy Tg(Mx1-cre)1Cgn/J
- 004222NOD.129P2(B6)-Il4tm1Cgn/DvsJ
- 004254NOD.Cg-Igh-6tm1Cgn Tg(IghelMD4)4Ccg/Dvs
- 004266NOD.Cg-Il10tm1Cgn/DvsJ
- 004291NOD.Cg-Il10tm1Cgn Il4tm1Cgn/DvsJ
- 004326C3Bir.129P2(B6)-Il10tm1Cgn/Lt
- 004333C.129P2(B6)-Il10tm1Cgn/J
- 004349C.129S2-Igh-6tm1Cgn/J
- 004368129-Il10tm1Cgn/J
- 004639NOD.129S2(B6)-Igh-6tm1Cgn/DoiJ
- 004781B6.129P2-Lyzstm1(cre)Ifo/J
- 004943NOD.Cg-Selltm1Tft Itgb7tm1Cgn/LtJ
- 004944NOD.B6-Itgb7tm1Cgn/2Lt
- 004982C3Bir.Cg-Il10tm1Cgn (D3Mit11-D3Mit19)/Lt
- 005306NODCaj.Cg-Igh-6tm1Cgn Tg(Igh-VB1-8/Igh-6m)1Mjsk/FswJ
- 005309NODCaj.Cg-Igh-6tm1Cgn Tg(Igh-VB1-8/Igh-6)2Mjsk/FswJ
- 02-00330Mouse models for liver immunity and therapeutic vaccinations
- 03-00144Mice with Kidney-specific Megalin Gene Defect
- 03-00145Kinin B1 Receptor Knock-Out Mice
- 03-00184Double-Transgenic Rats as a Tool to Study the Function of the Renin-Angiotensin System
- 03-00188Tryptophan Hydroxylase 1 Knockout Mice as a Tool to Study the Function of Serotonin
- 03-00189TGR(hKLK1) Transgenic rats as a Tool to Study the Kallikrein-Kinin System
- 03-00190Angiotensinogen Transgenic Mice TGM(rAOGEN)123
- 03-00202Renin Transgenic Rat TGR(mREN2)27
- 03-00238Conductin+/lacZ-mice as a model for Wnt-mediated tumorigenesis
- 03-00244CCR7 -/- mice: a model for studies on early immune reponses towards alloantigens
- 03-00249SLP3 mutant mice; an animal model lacking touch-evoked neuropathic pain
- 03-00300Animal model for endotoxic shock: transgenic rats with endothelial overexpression of kinin B1 receptors
- 03-00495A titin-DsRed knock-in mouse model to study cardiac and skeletal muscle disorders
- 03-00504A titin-eGFP knock-in mouse model to study cardiac and skeletal muscle disorders
- 11-00041PARP1 -/- mice: an animal model for cancer, autoimmune encephalomyelitis, arthritis and diabetes
- 11-00046GFP Transgenic Zebrafish strain as tool for studying kidney development
- 21-00013aMAG -/- mice: a model for studying pathological mechanisms of acquired demyelinating diseases
- 21-00013bTenascin-R knock-out mice
- 21-00013cCHL1 -/- mice: a model for studying the function of the close homologue of adhesion molecule L1
Antibodies
- Ref-No.Technology
- 03-00397Plasma cell-specific antibodies targeting BCMA for the treatment of multiple myeloma and autoimmune diseases
- 10-00064Highly-sensitive, highly-specific recombinant BMP-2 and BMP-14 antibodies
- 14-00013MAdL monoclonal antibody: A novel, highly specific and sensitive biomarker for adenocarcinomas of the lung
- 14-00022Man6P-specific single chain antibody fragment for detection of mucolipidosis and optimization of enzyme production for ERT
- 14-00073Improved endotoxin test for the quality control of biologics, overcoming low endotoxin recovery (LER) / low lipopolysaccharide recovery (LLR) phenomenon
- 23-00080Sars-CoV2 Neutralizing Antibodies
- 17beta-HSDcl
- ACP33 acidic cluster protein 33, ligand of CD4
- ActA purified, several epitopes
- Activation-induced cytidine deaminase (AID)
- Adenovirus type 5, E1B-55 kDa
- Adenovirus type 5, E4orf3
- Adenovirus type 5, L4-100 kDa
- Ago 1
- Ago 2
- APRIL
- APRIL-Phosphothreonin 224
- Blocking, FC gamma receptor, mouse, several isotypes
- Bop1 (human, block of proliferation)
- Borna gp18
- Borna p24
- Borna p40
- Borna p56
- BRD7, human, cellular
- C-24
- C-Myc, N-term
- C1q, C3, C4, mouse
- C1q, human
- Calcitonin
- Canine, CD44
- CBF1 (CSL, Su(H), RBP-1)
- CCR9
- CD154, human, monkey
- CD155
- CD3 epsilon chain
- CD4, mouse
- CD44, canine
- CD49c
- CD8, mouse
- CD83, human
- CD96
- Cdc45 cell division cycle 45p
- CDs, several, dog
- CDs, several, dog
- Cellular, BRD7, human
- Chicken, GTP cyclohydrolase
- Chicken, Interferon -γ
- Chicken, Interferon, alpha
- Chimerin
- CNG channel alpha3, rat
- CNG channel, cone type, rat
- Contactin1, mouse/chicken, mouse monoclonal
- Cyclodextrinase, Klebsiella oxytoca
- Cythohesin-1
- CYTIP
- Cytomegalievirus, glycoprotein gp40
- Dead box protein, DP103
- Dead box protein, DP103
- DLL1
- DNA pol delta p125 subunit
- DNA pol delta p50 subunit
- dog C1q
- Dog, several CDs
- Dog, several CDs
- DUTPase, EBV
- dUTPase, human
- E1B AP5 / HNRPUL1, Ribonucleoprotein hnRNP
- EBNA-3A
- EBV, BHRF1
- EBV, dUTPase
- EBV, EBNA1
- EBV, EBNA2, several epitopes
- EBV, EBNA2, wwp-peptide
- EBV, EBNA2A, several epitopes
- EBV, EBNA2b, several epitopes
- EBV, LMP1, several epitopes
- EBV, LMP2a, TP, several epitopes
- EDG
- ENV, Herv K10
- ENV, Herv K10
- ENV, Herv K10
- Epitopes, several, HIV-2, Nef protein
- Epsilon chain, Protein kinase C
- FC gamma receptor, mouse, blocking, several isotypes
- FITC
- FLT-1
- Formin-related protein in leukocytes 1
- Gag protein, Herv K10
- GTP cyclohydrolase, chicken
- GTP cyclohydrolase, human
- GTP cyclohydrolase, murine
- Guanylate binding protein GBP-1
- H2BUb1 (histone2B, ubiquintylated)
- H3X
- HCMV, US28
- Helt
- Herv K10, ENV
- Herv K10, ENV
- Herv K10, ENV
- Herv K10, gag protein
- HHV8, Kaposin
- HHV8, majorcapsid antigen (OFR 25)
- HHV8, minor capsid antigen (ORF 26)
- HHV8m, dUTPase
- Histone H3, K27 dimethylated
- Histone H4, K20 methylated
- HIV-2, Nef protein, several epitopes
- Hmd, Methanothermobacter
- Hmd, Methanothermobacter
- HSP72
- Human cellular, USP7/HAUSP
- Human origin recognition complex, OCR1 (hsORC)
- Human origin recognition complex, OCR2 (hsORC)
- Human origin recognition complex, OCR6 (hsORC)
- Human origin recognition complexOCR3 (hsORC)
- Human, C1q
- Human, CD154, monkey
- Human, cellular, BRD7
- Human, GTP cyclohydrolase
- Human, Importin a1
- Human, Importin a3
- Human, Importin a4
- Human, Importin a5
- Human, Importin a7
- Human, Methyltrans-ferase PRMT2
- Human, Notch1 intracellular, mouse
- Human, Notch3, intracellular
- Human, PAX9, murine
- Human, primase, p58, p48
- Human, Replication protein A, RPA32
- Human, Replication protein A, RPA70
- Hyperpolarization-activated Channel HCN1
- Hyperpolarization-activated channel HCN2
- Hyperpolarization-activated channel HCN3
- Hyperpolarization-activated channel HCN4
- Id, mouse lymphoma
- IgG2c, rat
- Ink4a
- Interferon alpha, chicken
- Isotypes, several, FC gamma receptor, mouse, blocking
- Isotypes, various, murine CD45
- Jul 1C11
- K20 methylated, Histone H4
- Kaposin, HHV8
- Karyopherin alpha2, Rch1
- Lambda light chain, rat
- LARK
- LARK/RBM4A
- LCMV-gp44 (Klon 25)
- Listeria monocytogenes Internalin B, Dhly pfrA 7973
- Listeria supernatant EDGprfA+
- Listeria supernatant EDGprfA+
- Listeria supernatant, complete
- Listeria supernatant, electro-elualed bands
- Listeria supernatant, eletro-elualed bands
- Ly1.1, Mouse anti mouse CD5
- Ly1.2, Mouse anti mouse CD5
- Lyt-1, mouse
- M161Ag
- MAD1
- Mage11
- MBP, maltose-binding protein, rat
- Methanothermobacter, Hmd
- Methanothermobacter, Hmd
- Methyltransferase PRMT2, human
- Monkey, human, CD154
- Motifantibody Poly DE
- Motifantibody Poly PRO
- Mouse anti mouse CD5, Ly1.1
- Mouse anti mouse CD5, Ly1.2
- Mouse anti-MBP, maltose binding protein
- Mouse anti-TrpE
- Mouse IRS-2
- Mouse IRS-2
- Mouse lymphoma, ld
- Mouse Lyt-1
- Mouse, C1q, C3, C4
- Mouse, CD4
- Mouse, CD8
- Mouse, RmT1, RmT2, RmT5, anti-Thy1
- Mouse, several Isotypes, FC gamma receptor, blocking
- Mouse, Thy1.2, spleen AKR
- Mouse, Thy1.2, spleen CBL
- Murine CD45, various isotypes
- Murine, GTP cyclohydrolase
- Murine, PAX9, human
- N-term, C-Myc
- NCAM AB – 5A2
- Nef protein, several epitopes, HIV-2
- Notch1 intracellular, mouse, human
- Notch3, intracellular, human
- OCR1, human origin recognition complex (hsORC)
- OCR2, human origin recognition complex (hsORC)
- OCR3, human origin recognition complex (hsORC)
- OCR6, human origin recognition complex (hsORC)
- PAX1
- PAX9, murine, human
- PAY, PC2 associated Q-rich protein
- PCNA
- Pes1 (human, pescadillo, rRNA processing factor)
- PF1
- PF63.1
- Pirin
- PP32
- Primase, p58, p48, human
- Protein kinase C, epsilon chain
- Protein kinase C, zeta chain
- Protein phosphatase 2A
- Rat anti-GST, synergistic to M-GST
- Rat anti-trpE
- Rat IgG2c
- Rat, lambda light chain
- Rat, MBP, maltose-binding protein
- RBM4A
- RBM4B
- RBM4B
- RBP (CBF1)
- Rch1, Karyopherin alpha2
- Replication protein A, RPA14
- Replication protein A, RPA32, human
- Replication protein A, RPA70, human
- Ribonucleoprotein hnRNP, E1B AP5 / HNRPUL1
- RISP
- RmT1, RmT2, RmT5, anti-Thy1, mouse
- RNA Polymerase II - CTD (non-phosporylated)
- RNA Polymerase II - CTD-Ser2-P
- RNA Polymerase II - CTD-Ser5-P
- RNA Polymerase II - CTD-Ser7-P
- RNA Polymerase II - CTD-Thr4-P
- RNA Polymerase II - CTD-Tyr1-P
- Sepiapterin reductase
- SH2D1A (X-linked lymphoproliferative disease XLP)
- TCR
- Tenascin-R
- Thy1.2, mouse, spleen AKR
- Thy1.2, mouse, spleen CBL
- TMEM59
- TRAF1
- TRAF2
- Transcription Cofactor NC2 alpha
- TrpE, Rat
- US28, HCMV
- USP7/HAUSP, human cellular
- UTP18 (human, rRNA processing factor)
- VIII41, ZBP-89
- WDR12 (WD-repeat 12, rRNA processing factor)
- wwp-peptide, EBV, EBNA2
- Yku70, yeast
- Zeta chain, Protein kinase C
Cardiovascular
- Ref-No.Technology
- 03-00230Modulation of ß-Catenin signalling for the treatment of cardiovascular diseases
- 03-00303RBM20 as a diagnostic marker for cardiovascular diseases
- 03-00319Stimulation of arteriogenesis for the prevention of myocardial infarction
- 03-00341KCNQ4 and KCNQ5 ion channels for the identification of selective channel function modulators
- 03-00389Volume-regulated anion channel VRAC as a target in drug discovery
- 03-00393Novel TPH inhibitors for the treatment of fibrotic diseases and pulmonary arterial hypertension (PAH)
- 15-00337Circulating microRNAs for diagnosis of Takotsubo-Cardiomyopathy
- 15-00371lncRNAs in therapy and diagnosis of disease related angiogenesis
- 15-00380Innovative biomarker for early prediction of atherosclerosis
- 15-00411Novel diagnostic for Peripartum cardiomyopathy (PPCM) in pregnant women
- 15-00551In vitro produced cardiac organoids as a novel tool for pharmacological research.
- 32-00049Preventing Vascular Calcification in Chronic Kidney Disease
- 32-00052Non-invasive cardiac pressure determination
- 43-00012Human blood vessel organoids for disease modelling and drug screening
- 44-00001Technology enabling a comprehensive analysis of blood flow in vessels
- 99-00126Novel gene therapy approach for cardiovascular diseases
Chemical Catalyst
- Ref-No.Technology
- 10-00105Biaryl coupling by Photosplicing
- 28-00019Inexpensive and highly efficient catalysts for the production of propene and related light olefins
- 28-00021Powerful and versatile catalysts for efficient and sustainable production of a wide range of cyclic organic carbonates from a broad range of internal and external epoxides
- 28-00021 (2)Efficient synthesis of even challenging (i.e. silyl-functionalized, fluorinated or bicyclic) cyclic organic carbonates under mild conditions e.g. for improved coatings, electrolytes and/or non-isocyanate polyurethanes
Chemical Synthesis
- Ref-No.Technology
- 10-00105Biaryl coupling by Photosplicing
- 28-00019Inexpensive and highly efficient catalysts for the production of propene and related light olefins
- 28-00021Powerful and versatile catalysts for efficient and sustainable production of a wide range of cyclic organic carbonates from a broad range of internal and external epoxides
- 28-00021 (2)Efficient synthesis of even challenging (i.e. silyl-functionalized, fluorinated or bicyclic) cyclic organic carbonates under mild conditions e.g. for improved coatings, electrolytes and/or non-isocyanate polyurethanes
CNS
- Ref-No.Technology
- 01-00903Novel method for direct neuronal reprogramming
- 01-00987DMD Gene Therapy Approach
- 03-00128New Key Drug Target for Psychiatric Disorders
- 03-00317Novel inhibitors of amyloid aggregate formation
- 03-00341KCNQ4 and KCNQ5 ion channels for the identification of selective channel function modulators
- 03-00363Small molecule inhibitors of STOML3 promise to treat neuropathic pain
- 03-00367Targeting of Autoantibodies to the alpha1-adrenergic receptor and the beta2-adrenergic receptor in Alzheimer’s and vascular dementia
- 10-00107Barnesins – novel natural small molecules as highly specific cysteine protease inhibitors
- 11-00057Innovative Nerve Sheath Tumor Therapy
- 15-00006Biocompatible nerve guidance conduit for neuroregeneration
- 15-00247Methylation biomarker to predict the response to monoaminergic antidepressants
- 15-00603Endoscopic device for stimulation of the laryngeal adductor reflex
- 16-00012SUCLG2 as determinator of CSF Aβ1-42 levels and attenuator of cognitive decline in Alzheimer’s disease
- 21-00002SynProt-A database for the proteome of synaptic junctions
- 21-00011Innovative diagnostic agent for high resolution mapping of acute cerebral ischemia
- 21-00022Novel device for minimally-invasive optical stimulation of nerve cells
- 21-00027Ferulic acid derivative FAE-20 as efficient neuroprotective agent and memory enhancer
- 23-00054Reduction of α-synuclein toxicity using PDE-1 inhibitor as a novel treatment in neurodegenerative synucleinopathies
- 23-00064Treating dementia and other brain disorders with natural glycans
- 23-00065Novel treatment of dementia-associated tauopathies
- 23-00069NMDAR targeted CAAR-T cell therapy
- 23-00074Treating C9orf72 ALS/FTD with active vaccination
- 24-00004PET-tracer for early diagnosis of Alzheimer's disease
- 43-00006Genetically engineered human 3D brain tumor models for disease modeling and compound evaluation
COVID-19 Related Technologies
- Ref-No.Technology
- 01-00897Lateral flow immunoassay with covalently clustered particles for enhanced sensitivity
- 02-00311Cystobactamids – novel antibacterials against gram-negative pathogens
- 03-00461Identifying Cellular States and Fate Transitions via Synthetic Locus Control Regions (sLCRs)
- 07-00080Innovative plasmids and cells for SARS-CoV-2-specific research
- 23-00080Sars-CoV2 Neutralizing Antibodies
- 43-00016SARSeq: Robust and highly multiplexed NGS assay for parallel detection of SARS-CoV2 and other respiratory infections
Dermatology
- Ref-No.Technology
- 01-00970Skin Tissue Model “SCAR-In-A-Dish”
- 03-00363Small molecule inhibitors of STOML3 promise to treat neuropathic pain
- 14-00097Anti-inflammatory, anti-bacterial agent for treatment of Atopic Dermatitis
- 14-00097Antimicrobial, endotoxine-neutralizing and anti-inflammatory agent for wound healing and treatment of bacterial skin and soft-tissue infections
Diagnostics
- Ref-No.Technology
- 01-00890Multiplexed Targeted Barcoding Technology for NGS Applications
- 01-00897Lateral flow immunoassay with covalently clustered particles for enhanced sensitivity
- 01-00967Novel optoacoustic endoscope for diagnostic purposes
- 01-00971Optoacoustic chemical microscopy
- 01-00976NMR glass capillary sealing device
- 02-00324Innovative DOTA-Linkers for Bacterial Targeting
- 02-00328Determination of Biofilm Dynamics via Impedance
- 02-00336Profiling of antimicrobial susceptibility and phylogenetic relations
- 02-00351Increased Availability and Efficacy of Aminoglycosides
- 02-00353High-throughput Screening for anti-herpesviridae Drugs
- 03-00245Intracellular Target for Systemic Lupus Erythematodes (SLE)
- 03-00302Aptamers for Treatment and Diagnosis of Autoantibody-based dilated Cardiomyopathy
- 03-00303RBM20 as a diagnostic marker for cardiovascular diseases
- 03-00305Sensitive PCR-based Biomarker for Identification of Residual Hodgkin Lymphoma Cells
- 03-00324Novel biomarkers for early diagnosis of Acute Kidney Injury
- 03-00341KCNQ4 and KCNQ5 ion channels for the identification of selective channel function modulators
- 03-00359mRNA interactome capture
- 03-00367Targeting of Autoantibodies to the alpha1-adrenergic receptor and the beta2-adrenergic receptor in Alzheimer’s and vascular dementia
- 03-00459Autofocus-control of a microscope including an electrically tunable lens
- 03-00462SPACE-Seq: Localizing Spatial Gene Expression on Single-Cell Level
- 03-00470FLAM-Seq: Genome-wide full-length mRNA and poly(A)-tail sequencing
- 05-00033New Candidate Gene for Diagnostic and Therapeutic Development to Combat Obesity-associated Diabetes
- 14-00013MAdL monoclonal antibody: A novel, highly specific and sensitive biomarker for adenocarcinomas of the lung
- 14-00022Man6P-specific single chain antibody fragment for detection of mucolipidosis and optimization of enzyme production for ERT
- 15-00150Semaphorin 5A as potential biomarker for graft vs. host disease
- 15-00171Prediction and therapy control of large vessel vasculitis
- 15-00247Methylation biomarker to predict the response to monoaminergic antidepressants
- 15-00281Diagnostic for Chronic Regional Pain Syndrome (CRPS)
- 15-00337Circulating microRNAs for diagnosis of Takotsubo-Cardiomyopathy
- 15-00371lncRNAs in therapy and diagnosis of disease related angiogenesis
- 15-00380Innovative biomarker for early prediction of atherosclerosis
- 15-00386lncRNA TapSaki predicts outcome in patients with Acute Kidney Injury
- 15-00411Novel diagnostic for Peripartum cardiomyopathy (PPCM) in pregnant women
- 15-00420Improved method of quantitative magnetic resonance lung imaging using ventilation-weighted Fourier decomposition
- 15-00502Predicting the therapeutic effect of BH3 mimetics
- 15-00523Novel Diagnostic for Hepatitis
- 15-00565Time-efficient assessment of pulmonary function via CT with low radiation doses
- 21-00011Innovative diagnostic agent for high resolution mapping of acute cerebral ischemia
- 24-00004PET-tracer for early diagnosis of Alzheimer's disease
- 24-00011Doped semiconductor substrates for lab on chip systems
- 24-00015Functionalized silicon nanoparticles for theranostic applications
- 32-00052Non-invasive cardiac pressure determination
- 32-00056Non-invasive measurement of myocardial power
- 42-00019Multiplex genetic engineering exploiting pyrimidine salvage pathway-based endogenous counterselectable markers
- 42-00022Stabilized minigastrin analogs for enhanced CCK2R targeting and applications in neuroendocrine tumor therapeutics and diagnostics
- 43-00003Highly Improved Reprogramming Efficiency for iPS Cell Generation
- 43-00016SARSeq: Robust and highly multiplexed NGS assay for parallel detection of SARS-CoV2 and other respiratory infections
- 44-00001Technology enabling a comprehensive analysis of blood flow in vessels
Drug Delivery
- Ref-No.Technology
- 02-00324Innovative DOTA-Linkers for Bacterial Targeting
- 02-00351Increased Availability and Efficacy of Aminoglycosides
- 02-00376Overcoming resistance - Innovative broad-spectrum inhibitors of Metallo- β-lactamases
- 07-00049JC virus-like particles based on VP1: an effective gene-therapeutic and retargeting delivery system
- 15-00241Method for coating of solid phase substrates and lipid surfaces with a lattice-like clathrin structure
- 32-00064Novel biomembranes based on defined electro-spun Poly (alkyl Cyanoacrylate)-fibers
- 99-00075DNA hydrogels from linear building blocks
Gastroenterology
- Ref-No.Technology
- 01-00967Novel optoacoustic endoscope for diagnostic purposes
- 03-00295Highly Effective, Innovative Treatment of Acute Liver Failure
- 03-00380Negative regulation of the IKK/NF-kB pathway activity by stabilisation of A20 mRNA – a new approach to treat inflammation
- 03-00393Novel TPH inhibitors for the treatment of fibrotic diseases and pulmonary arterial hypertension (PAH)
- 15-00436MicroRNA-125b-5p – a new treatment option for drug induced Acute Liver Failure
- 15-00523Novel Diagnostic for Hepatitis
Green Biotech
- Ref-No.Technology
- 06-00002Plant Virus Resistance
- 06-00059Epidermis-specific pathogen-inducible promoter for cereals
- 10-00106Gramibactin - A Novel Bifunctional Siderophore-NO-Donor for application in agriculture
- 42-00019Multiplex genetic engineering exploiting pyrimidine salvage pathway-based endogenous counterselectable markers
- 99-00108Triggering of plant immunity through bacterial hydroxy fatty acid metabolites
Immunology/Autoimmune
- Ref-No.Technology
- 01-00937Empowering T and NK cells for adoptive cell transfer (ACT) through engineering with PD-1:4-1BB
- 02-00330Mouse models for liver immunity and therapeutic vaccinations
- 03-00207bNovel Peptide Drug enhancing Immune Response in Patients suffering from Immune Suppression and Leukopenia
- 03-00245Intracellular Target for Systemic Lupus Erythematodes (SLE)
- 03-00291Multiple Target T Cell Receptor
- 03-00380Negative regulation of the IKK/NF-kB pathway activity by stabilisation of A20 mRNA – a new approach to treat inflammation
- 03-00397Plasma cell-specific antibodies targeting BCMA for the treatment of multiple myeloma and autoimmune diseases
- 03-00399/32-00019Human satellite cells as cell therapy for the treatment of muscle waisting disorders
- 03-00417Novel BCMA-CAR for the treatment of multiple myeloma and non-Hodgkin lymphoma (NHL)
- 14-00097Anti-inflammatory, anti-bacterial agent for treatment of Atopic Dermatitis
- 14-00097Antimicrobial, endotoxine-neutralizing and anti-inflammatory agent for wound healing and treatment of bacterial skin and soft-tissue infections
- 15-00150Semaphorin 5A as potential biomarker for graft vs. host disease
- 15-00171Prediction and therapy control of large vessel vasculitis
- 15-00379Mutation leading to Type 1 Diabetes mellitus and corresponding animal model
- 15-00461Novel treatment for septic diseases in newborns
- 15-00523Novel Diagnostic for Hepatitis
- 22-00009Quiescent B Cells for immune suppression in gene therapy
- 22-00017Functional IFN-gamma memory in CD4+ T cells: Method for improved T cell therapy and disease monitoring in autoimmune diseases
- 22-00020Bispecific antibodies for cell-type-specific TNF inhibition
- 23-00069NMDAR targeted CAAR-T cell therapy
- 32-00049Preventing Vascular Calcification in Chronic Kidney Disease
- 42-00022Stabilized minigastrin analogs for enhanced CCK2R targeting and applications in neuroendocrine tumor therapeutics and diagnostics
Infectious Diseases
- Ref-No.Technology
- 01-00758Generation of EBV-specific T-cells using virus-like particles facilitates adoptive treatment of EBV-associated diseases
- 01-00833VLP-based Epstein-Barr-Virus (EBV) vaccine
- 01-00897Lateral flow immunoassay with covalently clustered particles for enhanced sensitivity
- 01-00937Empowering T and NK cells for adoptive cell transfer (ACT) through engineering with PD-1:4-1BB
- 01-EBV-VLPA VLP-based prophylactic EBV vaccine
- 02-00226Inhibition of Pathogenic Biofilms on natural or synthetic surfaces
- 02-00278High-throughput test system for bacterial biofilms
- 02-00303Novel Myxopyronin Analogues and Myxopyronin Genecluster for Mutasynthesis
- 02-00311Cystobactamids – novel antibacterials against gram-negative pathogens
- 02-00312Novel Macrolide Antibiotics
- 02-00315Novel Chelocardin Derivatives – resistance breaking atypical tetracyclines with broad-spectrum antibiotic activity
- 02-00316Innovative Inhibitors of Pseudomonas Pathogenicity
- 02-00324Innovative DOTA-Linkers for Bacterial Targeting
- 02-00328Determination of Biofilm Dynamics via Impedance
- 02-00332Novel inhibitors of Pseudomonas aeruginosa LecB
- 02-00336Profiling of antimicrobial susceptibility and phylogenetic relations
- 02-00337Novel labyrinthopeptins as anti-viral agents
- 02-00351Increased Availability and Efficacy of Aminoglycosides
- 02-00353High-throughput Screening for anti-herpesviridae Drugs
- 02-00354Highly active Chlorotonil A Derivatives for the treatment of Malaria
- 02-00368Bivalent LecA Inhibitors Targeting Biofilm Formation of Pseudomonas aeruginosa
- 02-00376Overcoming resistance - Innovative broad-spectrum inhibitors of Metallo- β-lactamases
- 03-00295Highly Effective, Innovative Treatment of Acute Liver Failure
- 10-00026Novel Benzothiazinones, potent Tuberculosis antibiotics
- 10-00080Closthioamide- a new, unusual natural product with potent antibiotic activity against MRSA
- 10-00087Jagaricin – a novel antifungal natural compound
- 10-00088Bixiamycines –novel natural compounds with broad-spectrum antibiotic activity
- 10-00092Clostrubin - an unusual novel polyketide antibiotic
- 10-00107Barnesins – novel natural small molecules as highly specific cysteine protease inhibitors
- 14-00020Anti-inflammatory, LPS-neutralizing and anti-bacterial agent against sepsis and other severe bacterial infections
- 14-00020bSALP peptides are potent broad-spectrum anti-viral agents
- 14-00097Anti-inflammatory, anti-bacterial agent for treatment of Atopic Dermatitis
- 14-00097Antimicrobial, endotoxine-neutralizing and anti-inflammatory agent for wound healing and treatment of bacterial skin and soft-tissue infections
- 14-00098Targeting host lipid homeostasis to augment anti-mycobacterial treatment
- 15-00432Scalable and Continuous Production of iPSC-derived Macrophages for Therapeutic and Research Applications
- 15-00461Novel treatment for septic diseases in newborns
- 18-00021Use of cPLA2a-Inhibitors in therapy of flavivirus infection
- 22-00020Bispecific antibodies for cell-type-specific TNF inhibition
- 43-00016SARSeq: Robust and highly multiplexed NGS assay for parallel detection of SARS-CoV2 and other respiratory infections
Medical Devices
- Ref-No.Technology
- 01-00967Novel optoacoustic endoscope for diagnostic purposes
- 01-00971Optoacoustic chemical microscopy
- 03-00459Autofocus-control of a microscope including an electrically tunable lens
- 15-00091Optical Cochlea Stimulator
- 15-00096Laser Hearing Aid
- 15-00199The “i-scoop” – a new type of laryngoscope for normal and difficult airways
- 15-00343Automatic 3D modelling of craniofacial bone defects
- 15-00384Pre-sterilized modular surgical guidance device
- 15-00420Improved method of quantitative magnetic resonance lung imaging using ventilation-weighted Fourier decomposition
- 15-00490Irradiation device and method for optical cochlear implants and laser surgery sytems
- 15-00553Magnetic Artificial Shoulder Joint
- 15-00565Time-efficient assessment of pulmonary function via CT with low radiation doses
- 15-00603Endoscopic device for stimulation of the laryngeal adductor reflex
- 21-00003High-resolution multiwire electrode for chronic implantation in rodents
- 21-00019Microelectrode array with combined optical stimulation
- 24-00011Doped semiconductor substrates for lab on chip systems
- 32-00030Method and arrangement for identification and correction of optical aberrations
- 32-00048Adapter for inserting a dental implant
- 32-00052Non-invasive cardiac pressure determination
- 32-00056Non-invasive measurement of myocardial power
- 32-00058Blood transfusion safety system Cairos
- 32-00064Novel biomembranes based on defined electro-spun Poly (alkyl Cyanoacrylate)-fibers
- 44-00001Technology enabling a comprehensive analysis of blood flow in vessels
- 99-00075DNA hydrogels from linear building blocks
Metabolic Diseases
- Ref-No.Technology
- 01-00901Marker for beta-cell maturation
- 03-00248Use of MAS-G-Protein-coupled receptor agonists for the treatment of Metabolic Syndrome
- 03-00393Novel TPH inhibitors for the treatment of fibrotic diseases and pulmonary arterial hypertension (PAH)
- 05-00033New Candidate Gene for Diagnostic and Therapeutic Development to Combat Obesity-associated Diabetes
- 14-00022Man6P-specific single chain antibody fragment for detection of mucolipidosis and optimization of enzyme production for ERT
- 15-00379Mutation leading to Type 1 Diabetes mellitus and corresponding animal model
- 32-00049Preventing Vascular Calcification in Chronic Kidney Disease
- 43-00012Human blood vessel organoids for disease modelling and drug screening
Oncology
- Ref-No.Technology
- 01-00830Novel antibody to carbonic anhydrase XII with therapeutic and diagnostic potential for solid tumors and eye diseases
- 01-00937Empowering T and NK cells for adoptive cell transfer (ACT) through engineering with PD-1:4-1BB
- 02-00187Argyrin – A promising novel anti-cancer compound
- 02-00297Treatment of hepatocellular carcinoma
- 02-00350Novel Ratjadones as payloads in folate-, peptide-, and antibody-drug conjugates for the treatment of cancer
- 02-00352Carolacton as MTHFD2 inhibitor for cancer therapy
- 03-00239Epitope-Tag for surface-expressed T cell receptor (TCR) for administration of ex vivo modified cells
- 03-00305Sensitive PCR-based Biomarker for Identification of Residual Hodgkin Lymphoma Cells
- 03-00352Repurposing Niclosamide for (neo-)adjuvant cancer therapy
- 03-00389Volume-regulated anion channel VRAC as a target in drug discovery
- 03-00397Plasma cell-specific antibodies targeting BCMA for the treatment of multiple myeloma and autoimmune diseases
- 03-00413Improved Sleeping Beauty Transposon System for gene therapy: SB100X/pT4
- 03-00417Novel BCMA-CAR for the treatment of multiple myeloma and non-Hodgkin lymphoma (NHL)
- 03-00430Selective Inhibitors of Genotoxic Stress-Induced IKK/NF-κB Pathways for Cancer Therapy
- 10-00107Barnesins – novel natural small molecules as highly specific cysteine protease inhibitors
- 11-00054Innovative inhibitors of Notch trafficking and signalling for the treatment of cancer
- 11-00057Innovative Nerve Sheath Tumor Therapy
- 14-00013MAdL monoclonal antibody: A novel, highly specific and sensitive biomarker for adenocarcinomas of the lung
- 15-00302Novel inhibitor of mutated IDH1 in cancer therapy
- 15-00358COAT – an exceptionally efficient tumor vaccination approach
- 15-00371lncRNAs in therapy and diagnosis of disease related angiogenesis
- 15-00394Efficient oncolytic anti-tumor therapy based on adenovirus
- 15-00502Predicting the therapeutic effect of BH3 mimetics
- 15-00604Novel Diagnostic Marker For Early Detection Of Bladder Cancer
- 22-00017Functional IFN-gamma memory in CD4+ T cells: Method for improved T cell therapy and disease monitoring in autoimmune diseases
- 24-00015Functionalized silicon nanoparticles for theranostic applications
- 32-00059T-cell therapy of MYD88L265P-dependent B-cell lymphoma
- 42-00022Stabilized minigastrin analogs for enhanced CCK2R targeting and applications in neuroendocrine tumor therapeutics and diagnostics
- 43-00006Genetically engineered human 3D brain tumor models for disease modeling and compound evaluation
- 43-00012Human blood vessel organoids for disease modelling and drug screening
- 43-00016SARSeq: Robust and highly multiplexed NGS assay for parallel detection of SARS-CoV2 and other respiratory infections
Other Indications
- Ref-No.Technology
- 01-00903Novel method for direct neuronal reprogramming
- 03-00092Substances modulating primary haemostasis
- 03-00341KCNQ4 and KCNQ5 ion channels for the identification of selective channel function modulators
- 03-00389Volume-regulated anion channel VRAC as a target in drug discovery
- 03-00399/32-00019Human satellite cells as cell therapy for the treatment of muscle waisting disorders
- 03-00400Novel method for isolation and cultivation of ground state cells from heterogenous human pluripotent stem cell cultures
- 03-00413Improved Sleeping Beauty Transposon System for gene therapy: SB100X/pT4
- 10-00107Barnesins – novel natural small molecules as highly specific cysteine protease inhibitors
- 11-00060Novel treatment or prevention of age-related diseases extending lifespan
- 15-00154Novel method for serum-free generation of respiratory epithelial cells
- 15-00241Method for coating of solid phase substrates and lipid surfaces with a lattice-like clathrin structure
- 15-00358COAT – an exceptionally efficient tumor vaccination approach
- 15-00565Time-efficient assessment of pulmonary function via CT with low radiation doses
- 32-00030Method and arrangement for identification and correction of optical aberrations
- 32-00064Novel biomembranes based on defined electro-spun Poly (alkyl Cyanoacrylate)-fibers
- 42-00019Multiplex genetic engineering exploiting pyrimidine salvage pathway-based endogenous counterselectable markers
Research Tools
- Ref-No.Technology
- 01-00366Human Voxel Models
- 01-00890Multiplexed Targeted Barcoding Technology for NGS Applications
- 01-00901Marker for beta-cell maturation
- 01-00903Novel method for direct neuronal reprogramming
- 01-00940Mammary organoids derived from primary human breast epithelial cells
- 01-00970Skin Tissue Model “SCAR-In-A-Dish”
- 01-00971Optoacoustic chemical microscopy
- 01-00976NMR glass capillary sealing device
- 02-00116New viral packaging cell line
- 02-00336Profiling of antimicrobial susceptibility and phylogenetic relations
- 02-00353High-throughput Screening for anti-herpesviridae Drugs
- 03-00125Frog Prince: A Highly Active Transposon System For Insertional Mutagenesis, Gene-Trapping, and Gene Transfer in Vertebrates
- 03-00128New Key Drug Target for Psychiatric Disorders
- 03-00219Gene therapy protein expression technology
- 03-00251Stable Gene Transfer with Hyperactive Sleeping Beauty Transposase SB100X
- 03-00341KCNQ4 and KCNQ5 ion channels for the identification of selective channel function modulators
- 03-00359mRNA interactome capture
- 03-00389Volume-regulated anion channel VRAC as a target in drug discovery
- 03-00390Genome Architecture Mapping
- 03-00399/32-00019Human satellite cells as cell therapy for the treatment of muscle waisting disorders
- 03-00400Novel method for isolation and cultivation of ground state cells from heterogenous human pluripotent stem cell cultures
- 03-00413Improved Sleeping Beauty Transposon System for gene therapy: SB100X/pT4
- 03-00453Homology Independent Genomic Sequence Replacement
- 03-00459Autofocus-control of a microscope including an electrically tunable lens
- 03-00461Identifying Cellular States and Fate Transitions via Synthetic Locus Control Regions (sLCRs)
- 03-00462SPACE-Seq: Localizing Spatial Gene Expression on Single-Cell Level
- 03-00470FLAM-Seq: Genome-wide full-length mRNA and poly(A)-tail sequencing
- 07-00049JC virus-like particles based on VP1: an effective gene-therapeutic and retargeting delivery system
- 07-00080Innovative plasmids and cells for SARS-CoV-2-specific research
- 11-00035Cell wall-less bacteria (L-forms) for high yield heterologous protein expression
- 11-00053High quality tubulin and microtubule-associated proteins: tau, MAP1 and MAP2 as research tools
- 14-00004High-throughput assay for screening the stability of peptide drugs in proteolytic environments
- 14-00013MAdL monoclonal antibody: A novel, highly specific and sensitive biomarker for adenocarcinomas of the lung
- 14-00022Man6P-specific single chain antibody fragment for detection of mucolipidosis and optimization of enzyme production for ERT
- 14-00073Improved endotoxin test for the quality control of biologics, overcoming low endotoxin recovery (LER) / low lipopolysaccharide recovery (LLR) phenomenon
- 15-00420Improved method of quantitative magnetic resonance lung imaging using ventilation-weighted Fourier decomposition
- 15-00432Scalable and Continuous Production of iPSC-derived Macrophages for Therapeutic and Research Applications
- 15-00551In vitro produced cardiac organoids as a novel tool for pharmacological research.
- 21-00002SynProt-A database for the proteome of synaptic junctions
- 21-00022Novel device for minimally-invasive optical stimulation of nerve cells
- 22-00022Gene List Significance Index
- 24-00004PET-tracer for early diagnosis of Alzheimer's disease
- 24-00011Doped semiconductor substrates for lab on chip systems
- 24-00015Functionalized silicon nanoparticles for theranostic applications
- 24-00027DNA encircled bilayers (DEB) for the study of membrane proteins
- 32-00030Method and arrangement for identification and correction of optical aberrations
- 43-00003Highly Improved Reprogramming Efficiency for iPS Cell Generation
- 43-00004CRISPR Switch: Inducible sgRNA expression for tightly regulated, efficient & safer CRISPR/Cas9 genome editing
- 43-00006Genetically engineered human 3D brain tumor models for disease modeling and compound evaluation
- 43-00012Human blood vessel organoids for disease modelling and drug screening
- 99-00075DNA hydrogels from linear building blocks
Software
- Ref-No.Technology
- 01-00366Human Voxel Models
- 03-00431CrispRGold - Design of efficient Crispr/Cas sgRNA sequences
- 11-00052KILAPE – Automated scaffolding and gap filling of large, complex genomes
- 15-00420Improved method of quantitative magnetic resonance lung imaging using ventilation-weighted Fourier decomposition
- 15-00565Time-efficient assessment of pulmonary function via CT with low radiation doses
- 22-00022Gene List Significance Index
- 32-00056Non-invasive measurement of myocardial power
- 32-00058Blood transfusion safety system Cairos
Technical Equipment
- Ref-No.Technology
- 01-00971Optoacoustic chemical microscopy
- 01-00976NMR glass capillary sealing device
- 03-00459Autofocus-control of a microscope including an electrically tunable lens
- 15-00490Irradiation device and method for optical cochlear implants and laser surgery sytems
- 21-00022Novel device for minimally-invasive optical stimulation of nerve cells
- 32-00030Method and arrangement for identification and correction of optical aberrations
- 32-00058Blood transfusion safety system Cairos
Therapeutics
- Ref-No.Technology
- 01-00758Generation of EBV-specific T-cells using virus-like particles facilitates adoptive treatment of EBV-associated diseases
- 01-00830Novel antibody to carbonic anhydrase XII with therapeutic and diagnostic potential for solid tumors and eye diseases
- 01-00833VLP-based Epstein-Barr-Virus (EBV) vaccine
- 01-00937Empowering T and NK cells for adoptive cell transfer (ACT) through engineering with PD-1:4-1BB
- 01-00987DMD Gene Therapy Approach
- 01-EBV-VLPA VLP-based prophylactic EBV vaccine
- 02-00187Argyrin – A promising novel anti-cancer compound
- 02-00226Inhibition of Pathogenic Biofilms on natural or synthetic surfaces
- 02-00297Treatment of hepatocellular carcinoma
- 02-00311Cystobactamids – novel antibacterials against gram-negative pathogens
- 02-00312Novel Macrolide Antibiotics
- 02-00315Novel Chelocardin Derivatives – resistance breaking atypical tetracyclines with broad-spectrum antibiotic activity
- 02-00316Innovative Inhibitors of Pseudomonas Pathogenicity
- 02-00332Novel inhibitors of Pseudomonas aeruginosa LecB
- 02-00337Novel labyrinthopeptins as anti-viral agents
- 02-00350Novel Ratjadones as payloads in folate-, peptide-, and antibody-drug conjugates for the treatment of cancer
- 02-00351Increased Availability and Efficacy of Aminoglycosides
- 02-00352Carolacton as MTHFD2 inhibitor for cancer therapy
- 02-00353High-throughput Screening for anti-herpesviridae Drugs
- 02-00354Highly active Chlorotonil A Derivatives for the treatment of Malaria
- 02-00368Bivalent LecA Inhibitors Targeting Biofilm Formation of Pseudomonas aeruginosa
- 02-00376Overcoming resistance - Innovative broad-spectrum inhibitors of Metallo- β-lactamases
- 03-00092Substances modulating primary haemostasis
- 03-00207aNovel adjuvant class for use in immunotherapy and vaccination.
- 03-00207bNovel Peptide Drug enhancing Immune Response in Patients suffering from Immune Suppression and Leukopenia
- 03-00248Use of MAS-G-Protein-coupled receptor agonists for the treatment of Metabolic Syndrome
- 03-00251Stable Gene Transfer with Hyperactive Sleeping Beauty Transposase SB100X
- 03-00291Multiple Target T Cell Receptor
- 03-00295Highly Effective, Innovative Treatment of Acute Liver Failure
- 03-00302Aptamers for Treatment and Diagnosis of Autoantibody-based dilated Cardiomyopathy
- 03-00317Novel inhibitors of amyloid aggregate formation
- 03-00319Stimulation of arteriogenesis for the prevention of myocardial infarction
- 03-00352Repurposing Niclosamide for (neo-)adjuvant cancer therapy
- 03-00363Small molecule inhibitors of STOML3 promise to treat neuropathic pain
- 03-00367Targeting of Autoantibodies to the alpha1-adrenergic receptor and the beta2-adrenergic receptor in Alzheimer’s and vascular dementia
- 03-00380Negative regulation of the IKK/NF-kB pathway activity by stabilisation of A20 mRNA – a new approach to treat inflammation
- 03-00393Novel TPH inhibitors for the treatment of fibrotic diseases and pulmonary arterial hypertension (PAH)
- 03-00397Plasma cell-specific antibodies targeting BCMA for the treatment of multiple myeloma and autoimmune diseases
- 03-00399/32-00019Human satellite cells as cell therapy for the treatment of muscle waisting disorders
- 03-00413Improved Sleeping Beauty Transposon System for gene therapy: SB100X/pT4
- 03-00417Novel BCMA-CAR for the treatment of multiple myeloma and non-Hodgkin lymphoma (NHL)
- 03-00430Selective Inhibitors of Genotoxic Stress-Induced IKK/NF-κB Pathways for Cancer Therapy
- 10-00026Novel Benzothiazinones, potent Tuberculosis antibiotics
- 10-00080Closthioamide- a new, unusual natural product with potent antibiotic activity against MRSA
- 10-00087Jagaricin – a novel antifungal natural compound
- 10-00088Bixiamycines –novel natural compounds with broad-spectrum antibiotic activity
- 10-00092Clostrubin - an unusual novel polyketide antibiotic
- 11-00054Innovative inhibitors of Notch trafficking and signalling for the treatment of cancer
- 11-00057Innovative Nerve Sheath Tumor Therapy
- 11-00060Novel treatment or prevention of age-related diseases extending lifespan
- 14-00020Anti-inflammatory, LPS-neutralizing and anti-bacterial agent against sepsis and other severe bacterial infections
- 14-00020bSALP peptides are potent broad-spectrum anti-viral agents
- 14-00097Antimicrobial, endotoxine-neutralizing and anti-inflammatory agent for wound healing and treatment of bacterial skin and soft-tissue infections
- 15-00302Novel inhibitor of mutated IDH1 in cancer therapy
- 15-00358COAT – an exceptionally efficient tumor vaccination approach
- 15-00371lncRNAs in therapy and diagnosis of disease related angiogenesis
- 15-00385LNCRNAS GADLOR 1 + 2 FOR DIAGNOSIS AND TREATMENT OF CARDIAC HYPERTROPHY
- 15-00394Efficient oncolytic anti-tumor therapy based on adenovirus
- 15-00432Scalable and Continuous Production of iPSC-derived Macrophages for Therapeutic and Research Applications
- 15-00436MicroRNA-125b-5p – a new treatment option for drug induced Acute Liver Failure
- 15-00461Novel treatment for septic diseases in newborns
- 18-00021Use of cPLA2a-Inhibitors in therapy of flavivirus infection
- 21-00027Ferulic acid derivative FAE-20 as efficient neuroprotective agent and memory enhancer
- 22-00009Quiescent B Cells for immune suppression in gene therapy
- 22-00017Functional IFN-gamma memory in CD4+ T cells: Method for improved T cell therapy and disease monitoring in autoimmune diseases
- 22-00020Bispecific antibodies for cell-type-specific TNF inhibition
- 23-00064Treating dementia and other brain disorders with natural glycans
- 23-00065Novel treatment of dementia-associated tauopathies
- 23-00069NMDAR targeted CAAR-T cell therapy
- 23-00080Sars-CoV2 Neutralizing Antibodies
- 32-00059T-cell therapy of MYD88L265P-dependent B-cell lymphoma
- 42-00022Stabilized minigastrin analogs for enhanced CCK2R targeting and applications in neuroendocrine tumor therapeutics and diagnostics
- 99-00126Novel gene therapy approach for cardiovascular diseases
Vaccines
- Ref-No.Technology
- 01-00758Generation of EBV-specific T-cells using virus-like particles facilitates adoptive treatment of EBV-associated diseases
- 01-00833VLP-based Epstein-Barr-Virus (EBV) vaccine
- 01-EBV-VLPA VLP-based prophylactic EBV vaccine
- 02-00116New viral packaging cell line
- 02-00158Cyclic di-Nucleotides as adjuvants
- 02-00160Hexosylceramides as adjuvants
- 02-00280Innovative lipopeptide-conjugates as mucosal adjuvants - BPPcysPep-MPEG
- 02-00361Cyclic-di-AMP: a promising adjuvant for neonatal vaccines
- 03-00207aNovel adjuvant class for use in immunotherapy and vaccination.
- 15-00358COAT – an exceptionally efficient tumor vaccination approach
- 15-00377Fast and Efficient Method for Chemoenzymatic Production of Neisseria meningitidis Glycoconjugate Vaccines
- 15-00527New Class of Bacterial Capsule Polymerases for Cost-Effective Synthesis of Glycoconjugate Vaccines
- 23-00074Treating C9orf72 ALS/FTD with active vaccination
